Cat.#: ACPP-1327
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1086 | Synthetic Nanodisc Human Somatostatin Receptor 2 Protein (AC1086) | 10 µg | inquiry |
| ACPP-1448 | Human I TAC Protein, His (AC1448) | 5 µg | inquiry |
| ACPP-1658 | Human Acrp30 Protein, His (AC1658) | 10 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1005 | Recombinant Human CNTF Protein (AC1005) | 50 µg | inquiry |
| ACPP-1140 | Recombinant Human CCR5 Protein (Fc Tag) (AC1140) | 50 µg | inquiry |
| ACPP-1643 | Human Transthyretin Protein (AC1643) | 5 µg | inquiry |
| ACPP-1253 | Pin1 Blocking Peptide (AC1253) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.